We investigated the immunohistochemical localization of androgen receptor (AR) using a polyclonal antibody for 55 KD recombinant human AR in human tissues fixed with 4% paraformaldehyde solution and embedded in paraffii. Immunoreactive AR was restricted to the nuclei of various tissues. Among the well-known androgen target organs, secretory cells and basal cells of the prostate, spermatogonia, spermatocytes, Sertoli cells and Leydig cells of the testis, epithelial cells of the rete testis, fibroblasts in the whole organ, squamous cells, sweat gland and hair follicle cells of the skin, and hepatocytes of the liver were positive for AR. In addition, smooth musde cells of the prostate, uterus, urinary bladder, gastrointestinal tract, arteries, and arterioles were strongly immunoreactive for AR. Cardiac muscle and striated muscle of psoas were positive for AR. Acinar cells, ductal cells, and myoepithelial cells of the breast, endocervical and endometrial cells of the uterus, cyto-and syncytiotrophoblast of the chorionic villi, and tubules of the kidney were also positive for AR. Most FSH, LH, and some GH endoctine cells in the anterior and posterior lobes of the pituitary gland, follicular cells of the thyroid gland, and adrenocortical cells were positive for AR. Cells immunoreactive for AR were ubiquitously distributed throughout the entire body. The present study demonstrated the diversity of androgen effects on many target tissues. (1 Hisrochem   Cyrochem 41:671678, 1993) 
Introduction
The sex steroids provoke the development and determination of the embryonic reproductive system, masculinize or defeminize the brain at birth, control development of secondary sexual characteristics, control synthesis of protein in muscle, bone, and skin, and govem reproduction and reproductive behavior in the adult. Analysis of the hormone receptors is essential for an understanding of both the origins of complex regulatory systems and their contribution to maintenance of the organism. The immunocytochemical detection of androgen receptor (AR) in the target tissues is of great importance for an understanding of AR roles in the action of steroid hormones and for the simplification and extension of receptor characterization in various diseases, particularly in hormone-dependent cancers (16) . The recent cloning of AR cDNA by Chang et al. (3) and Lubahn et al. (12) has led to the production of fusion proteins containing AR and also of anti-AR antibodies (2, 4, 10) . Application of immunohistochemical staining of AR has been performed in normal tissues (10, 18, 20) and in prostatic hyperplasia and carcinoma (11, 13, 19) . The localization of human AR has been visualized immunocytochemically by use of monoclonal antibodies and polyclonal antibodies (2, 4, 10, 13, 18, 19, 21) . The immunoreactive localization of AR has been defined as the nuclei of the target cells of the prostate, male reproductive cells, and a variety of other organs of human, rat, and mouse. Most of those tissues examined were frozen sections. Paraffin sections, however, provide better preservation of morphology and can be examined retrospectively. Using a polyclonal antibody specific for the fusion protein of human AR (NH27), we examined the cellular localization of AR in various tissues, both those fixed with 4% paraformaldehyde solution and those embedded in paraffin. specimens. Sources of the tissues examined were as follows: prostates and testes were from patients with prostatic hyperplasia and/or prostatic carcinoma, uterus and ovaries were from uterine leiomyoma andlor uterine carcinoma. breasts w e~e from fibrocystic disease or breast carcinoma, adrenals were from pheochromocytoma and renal cell carcinoma, placentas were from spontaneous abortion, livers were from needle biopsy specimens from patients with viral hepatitis or liver cirrhosis, and the rest were from autopsies that were performed within 3 hr after death. Non-diseased or non-neoplastic areas of those organs, except liver, were submitted for investigation. All tissues were fixed in 4% paraformaldehyde solution for 18 hr at 4'C and were embedded in paraffin. A portion of the each specimen was fixed with 4% paraformaldehyde solution. frozen with liquid nitrogen, and mounted in Tissue-Tek OCT compound, and then cut onto gelatin-coated slides for immunostaining. Some of the specimens were snap-frozen immediately after surgical removal and were mounted in Tissue-Tek OCT compound, cut at a thickness of 4 pm, and then fixed in 4% paraformaldehyde solution for 10 min.
Antibodies. A polyclonal antibody (NH27) for 55 KD human androgen receptor fusion protein was raised in rabbit. This antibody did not crossreact with estrogen receptor and progesterone receptor. Specificity of the antibody was confirmed with Western blot analysis and immunoprecipitation assay. Details of the antibody have been described elsewhere (14) . Briefly, pSGAR2, a full-length human androgen receptor (hAR) expression plasmid DNA, was constructed by inserting the 3.3 KB of BglII-BamHI fragment of pGEM-32 hAR into the BglII site of the pSG5 DNA (Stratagene; La Jolla, CA). To enhance the expression of hAR in PC-3 cells, 5 pg of pSVo plasmid DNA that expresses SV40 large T-antigen was employed with 10 pg of pSGAR2. Two days after transfection, total cell proteins were prepared and subjected to Western blot analysis. A 616 BP of NruI-Hind11 fragment of pGEM-3Z hAR was inserted into the blunt-ended BamHI and Hind11 sites of the pGEMEX-1 vector (Promega; Madison, WI). The resulting plasmid, pGEM616, produces about 55 KD hAR fusion protein. A 1.6 KBP of Sau3A-Sau3A fragment that overlaps the 616 BP fragment was inserted into the BamHI site of the PET-3c vector. The resulting plasmid, pETS1.6. produces about 66 KD hAR fusion protein. The 55 KD hAR fusion protein was expressed forming inclusion bodies in bacteria. The >5 KD hAR fusion protein was separated on a 10% preparative SDS-polyacrylamide gel and visualized by immersing the gel in 0.25 M KCI. The gel slice was mixed with Freund's complete adjuvant and used for immunization of rabbits. The resulting serum, NH27, was affinity-purified using a nitrocellulose filter on which the 66 KD hAR fusion protein was immobilized.
A monoclonal antibody for recombinant androgen receptor (AN [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] produced by Chang and co-workers (2, 4, 13) was purchased from Affinity Bioreagents (Neshanic Station, NJ) to compare with our polyclonal antibody. Antibodies for pituitary hormones including ACTH, growth hormone (GH), prolactin (PRL.), follicle-stimulating hormone (FSH-beta subunit), luteinizing hormone (LH-beta subunit), and thyroid stimulating hormone (TSH-beta subunit) were purchased from Incstar, Stillwater, MS (ACTH), DakoPatts. Uppsala, Denmark (GH, PIU, FSH), and UCB-BioProducts, Brussels, Belgium (LH, FSH).
Immunohistochemical Procedure. Sections were incubated in 10% protease (Sigma Type 4; St Louis, MO) for 10 min at 37°C and then endogenous peroxidase was blocked with 0.75% hydrogen peroxide in methanol for 15 min. In the sections for monoclonal antibody, the step for blocking endogenous peroxidase was omitted on the basis of the manufacturer's recommendation. Normal goat serum and normal rabbit serum were incubated to decrease nonspecific staining. Sections were then incubated for 18 hr at 4'C with rabbit polyclonal antibody (NH27) 1:400, and rat monoclonal antibody (AN 1-15) 1:lO. After washing, the sections were incubated with biotinylated goat anti-rabbit IgG and rabbit anti-rat IgG, and then with streptavidin-biotin-peroxidase complex, followed by a 3,3'-diaminobenzidine tetrahydrochloride and hydrogen peroxide mixture. The streptavidin-biotin-peroxidase complex method was employed using a Histofine SAB-PO kit (Nichirei; Tokyo, Japan) for the polyclonal antibody and biotin-avidin kit (Vector Labs; Burlingame, CA) for the monoclonal antibody. Counterstaining with methyl green was performed. As a negative control, pre-immune rabbit serum was used instead of the polyclonal antibody (NH27). The co-localization of AR with anterior pituitary proteins was carried out using a double-labeling technique.
Results
Our initial studies compared frozen sections and pardimembedded sections from the same tissues fixed with 4% paraformaldehyde solution. Both methods showed specific immunocytochemical staining in the nuclei of epithelial and smooth muscle cells of the prostate. No cytoplasmic staining was observed. The optional dilution of the antibodies was different, being 1:1500 for frozen sections VS 1:400 for paraffin-embedded sections. Comparing the immunoreactive staining with different fixation procedures, no differences in the distribution of AR immunoreactivity were noted when 4% paraformaldehyde-fixed, paraffin-embedded sections were compared with frozen sections from the same specimen. However, morphological preservation was markedly better in the paraffinembedded sections than in the frozen sections. In addition to the type of fixative, fixation time was important. Specimens obtained by transrectal biopsy (TLJR) and fixed immediately for 12 hr at 4°C showed good results, but surgically obtained organs fixed for more than 24 hr without appropriate slicing exhibited decreased or absent immunoreactivity.
Next, we compared the immunoreactivity of the monoclonal antibody (AN [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] and the polyclonal antibody (NH-27) on serial sections. Both antibodies showed the same immunoreactivity in the nuclei of the prostate. The negative control using pre-immune rabbit serum instead of anti-hAR showed no immunoreactive cells.
Distribution of the immunoreactive cells is summarized in Eble 1 with comparison to previous studies. Immunostaining was restricted to the nuclei in all of the cells of the different tissues.
In the prostate gland, the secretory cells, basal cells, fibroblasts, and smooth muscle cells were all strongly immunoreactive for anti-AR serum (Figures la and lb) . Nuclear staining was also observed in Sertoli cells, peritubular myoid cells, Leydig cells, spermatogonia, and spermatocytes of the testis (Figure 2) . Smooth muscle cells of the arteries (Figure 3) ' uterine myometrium, propria muscularis of GI tract, and urinary bladder were consistently strongly positive. Cardiac muscle (Figure 4 ) and striated muscle of the psoas were also immunoreactive for the AR antibody. Fibroblasts throughout the entire body, including the ovary, and fat cells around various organs, also exhibited populations of AR-positive cells. Acinar cells, ductal cells, and myoepithelial cells of the breast, syncytiotrophoblast and cytotrophoblast of the placenta (Figure 5 ) , uterine endometrial cells, and follicular cells of the thyroid gland were also immunostained for AR. In the pituitary gland, most of the FSH cells ( Figure 6 ), LH cells, and some of the GH cells were target cells of androgen. In the skin, squamous cells of epidermis, hair follicle cells, and sweat gland cells also had AR immunoreactivity (Figure 7) . Finally, nuclei of hepatocytes demonstrated AR immunoreactivity (Figure 8 ).
Discussion
In recent years, molecular cloning and structural analysis of cDNAs for various steroid receptors have made it possible to analyze the importance of different receptor domains in binding DNA and steroid hormones. Fusion proteins for steroid hormone response elements have made it possible to obtain antibodiesspecific to them. Improvement of techniques for immunohistochemical staining have enabled detection of estrogen and progesterone receptors in paraf- fin sections (8, 9, 15, 16, 20, 23) . The results of immunocytochemical staining agreed with those of the dextran-coated charcoal assay, indicating that the receptors can be demonstrated immunohistochemically by use of paraffin as well as frozen sections (5, 20) . Immunohistochemical staining of ER (5, 8, 9, 15, 20, 23) in human breast cancer and thyroid cancer and of PR (1, 6, 16, 17) in female genital organs gave consistent findings, showing that these sex steroid receptors were confined to the nuclei of immunoreactive cells. The present study indicates that it is possible to perform a reliable AR analysis on formalin-fiied, paraffin-sections by an immunohistochemical technique with the polyclonal antibody AR-NH27. Pre-treatment of paraffin sections with pronase greatly increased the sensitivity of the immunoreactivity and provided excellent staining, as previously reported (5,8,15,20) . The pronase may unmask AR antigenic determinants present in the nuclei of the cells that are usually obscured by the formalin fixation procedures. The development of a reproducible, sensitive, and specific technique for evaluating AR status in formalin-fixed tissues allows the long-term retrospective evaluation of target cells of androgen with emphasis on androgen-dependent tumors. Furthermore, morphological preservation was markedly improved in paraffin-embedded tissues as compared with frozen sections. The prostate is a well-known target organ of androgen. Autoradiographic staining of AR in the fetal prostate (22) was seen mainly in the stroma, and an abundance of 5-alpha-reductase, which converts testosterone into dihydrotestosterone, was also present in the stroma. Conversely, immunostaining of AR was mainly detected in the epithelial compartment (21). Using polyclonal antibodies, Husmann et al. (10) and our present study demonstrated that both epithelial cells and stromal cells of the prostate showed strong immunoreactivity. Although previous studies (12,18,21) have reported that germ cells of the testis were negative for AR, our investigation revealed obvious immunostaining of spermatogonia and spermatocytes. This discrepancy in immunostaining was probably due to dlfferences in the antibodies. Our results support the hypothesis that testosterone regulates spermatogenesis directly. The present study revealed that not only striated muscle but also smooth muscle and cardiac muscle had androgen receptors. We should emphasize that smooth muscle of vessel walls showed especially strong immunoreactivity. Although AR in smooth muscle has not been studied extensively, Takeda et al. (21) showed that most of the smooth muscle layers of reproductive organs of both sexes contain AR-positive cells. Winborn et al. (24) demonstrated by autoradiography that the smooth muscle of the digestive tract is positive for AR. Both breast and uterus are well-known target organs of estrogen and progesterone and they have both ER and PR (17). Our study further demonstrates that they also have AR and are regulated by all sex steroids. Both FSH and LH regulate androgen synthesis and release and AR was also identified, which confirmed that there is a feedback system between gonadotropin and androgen. In agreement with Takeda et al. (18) , the present study showed that AR is ubiquitously distributed in the whole body. Not only AR proteins but also the presence of AR mRNA has been confirmed in various organs of female rats by Northern blot analysis (7) . in which AR mRNA was detected in adrenal gland, uterus, aorta, adipose tissue, kidney, spleen, heart, lung, large intestine, stomach, small intestine, and liver. Thus, it was revealed that androgen plays important roles in many organs, in addition to the male reproductive organs. By employing an antibody produced against a 55 KD hAR fusion protein (NH26), further investigation on paraffin-embedded tissues from various diseases previously removed at surgery could be performed retrospectively.
